AUP1602-C

BIOLOGICAL2 trials

Sponsors

Aurealis Oy

Conditions

Diabetic Foot Ulcer

Phase 1

Treatment of Diabetic Foot Ulcers With AUP1602-C

CompletedNCT04281992

Aurealis OyDiabetic Foot Ulcer

Start: 2020-01-28End: 2023-03-20Updated: 2023-09-28

Phase 2

Evaluation of AUP12602-C as New Topical Treatment for DFUs (DIAMEND STUDY)

CompletedNCT06111183

Aurealis OyDiabetic Foot Ulcer

Start: 2023-07-21End: 2025-11-28Updated: 2026-02-12

Related Papers

Multi-target gene therapy AUP1602-C to improve healing and quality of life for diabetic foot ulcer patients: a phase I, open-label, dose-finding study

Therapeutic Advances in Endocrinology and Metabolism2024-05-018 citations

Engineered bacteria to accelerate wound healing: an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial.

2023-05-2524 citations

RJX Improves Wound Healing in Diabetic Rats

Frontiers in Endocrinology2022-06-0213 citations